Glaucoma research focuses on neurodegeneration

Article

The growing understanding that glaucoma is a neurodegenerative rather than ocular disease is to be the principal topic of discussion of the annual Glaucoma Research Foundation (GRF) benefit, to be held January 28 2009 in San Francisco, California, US.

The growing understanding that glaucoma is a neurodegenerative rather than ocular disease is to be the principal topic of discussion of the annual Glaucoma Research Foundation (GRF) benefit, to be held 28 January 2009 in San Francisco, California, US. The Catalyst For a Cure (CFC) research consortium, composed of neuroscientists and geneticists, will present a Research Overview of the notable breakthroughs made in 2008.

CFC research has this year established that oxidative stress affects the rate of glaucomatous cellular function loss, and that neuronal loss due to glaucoma is preceded by degeneration of the axons, indicating that glaucoma can be predicted by observing changes to genes and proteins. The CFC is now concentrating on studying general features of neurodegeneration in the hope of discovering a therapeutic or interventional treatment to arrest or the development or reverse the progression of glaucoma.

During the benefit, Rohit Varma, MD of the University of Southern California will receive the President's Award and H. Dunbar Hoskins Jr., MD, executive vice president of the American Academy of Ophthalmology, will be presented with the GRF's highest honour, The Catalyst Award.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.